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Introduction {#ccr3546-sec-0001}
============

Rhabdomyolysis, a syndrome of skeletal muscle cell damage, engenders the release of toxic intracellular materials into systemic circulation [1](#ccr3546-bib-0001){ref-type="ref"}. The pathogenesis of rhabdomyolysis is based on an increase in free ionized calcium in the cytoplasm [1](#ccr3546-bib-0001){ref-type="ref"}. Prompt diagnosis requires routine monitoring of serum creatine kinase (CK) activity in a patient with a suggestive history or clinical features [1](#ccr3546-bib-0001){ref-type="ref"}.

Serum concentrations of alanine (ALT) and aspartate (AST) aminotransferases have been regarded as markers of liver injury [2](#ccr3546-bib-0002){ref-type="ref"}. Measurement of ALT and AST enzymatic activity is still most commonly done to evaluate putative liver injury [2](#ccr3546-bib-0002){ref-type="ref"}. Blood concentrations of ALT and AST reflect liver cell membrane damage, with subsequent leakage of intracellular enzymes into circulation, especially the cytosolic ones [2](#ccr3546-bib-0002){ref-type="ref"}. Transaminases are reliable predictors of individual components including type 2 diabetes and decreased hepatic insulin sensitivity, coronary heart disease, atherothrombotic risk profile, and overall risk of cardiovascular and metabolic disease [2](#ccr3546-bib-0002){ref-type="ref"}. Therefore, routine testing of aminotransferases ALT and AST is now regarded as an indicator of "liver metabolic function" [2](#ccr3546-bib-0002){ref-type="ref"}.

Case History and Examination {#ccr3546-sec-0002}
============================

A 40‐year‐old man diagnosed with schizophrenia at the age of 17 had functioned stably in his community for more than two decades. A psychiatric clinic had prescribed haloperidol 3 mg and biperiden 1 mg for him. He had no known diagnosis of chronic liver disease. He denied using any non‐prescription or herbal supplement. His family history was negative for liver disease and genetic myopathy. We rejected the possibility of polydipsia by history using information from his mother. Three days before admission, his condition worsened suddenly. He was admitted to our hospital because of auditory hallucinations, delusions, and chaotic and aggressive behavior. For 2 weeks, he had not taken medicines but had worked intensely. Then, aggravation of psychotic symptoms occurred. When admitted, he presented abnormal behavior, agitation, self‐talking, self‐laughing, and aggression in the quiet room. He refused meals and beverages. At 165.8 cm height, his weight was 58.5 kg, implying his body mass index (BMI) as 21.3 kg/m^2^. Physical examination revealed 147/105 mmHg blood pressure, 113 beats/min heart rate, and 36.3 °C body temperature. Skin and mucous were not dry. He had no evidence of rigidity or muscle tenderness, or of hepatomegaly. Other system examination results were unremarkable. Baseline tests such as those of serum electrolytes, urine examination, thyroid hormones, chest X‐ray, brain CT, and electrocardiography all yielded normal results. Results of the main initial laboratory evaluations are presented in the Table [1](#ccr3546-tbl-0001){ref-type="table-wrap"}: serum CK, 6622 IU/L; serum AST, 208 IU/L; ALT, 68 IU/L; and serum myoglobin, 1644 ng/mL. On the 2nd day, he was diagnosed with rhabdomyolysis. Intravenous infusion containing 35 mmol/L sodium chloride with 20 mmol/L potassium chloride (Solita T3) was started at a rate of 100 mL/h, accompanied by restriction of oral fluids under physical restraint. Antipsychotics were indicated as causing neuroleptic malignant syndrome [3](#ccr3546-bib-0003){ref-type="ref"}. Therefore, we were unable to prescribe it to the patient because of elevated concentration of serum creatine kinase. Continued intravenous infusion caused positive balances and urine production. The individual value curve for CK, AST, ALT, alkaline phosphatase (ALP), and *γ*‐glutamyl transferase (GGT) during hospitalization is shown in the Fig. [1](#ccr3546-fig-0001){ref-type="fig"}. Actually, CK fell rapidly on the 4th day, although AST and ALT started to increase rapidly and mutually in parallel. The respective values of CK, AST, ALT, ALP, and GGT on the 8th day were 715, 388, 582, 212, and 43 IU/L. The AST/ALT ratio was 0.67. He had no symptoms or other stigmata of liver disease. Blood liver function tests were normal: total bilirubin, 1.02 mg/dL; cholinesterase, 221 IU/L; hepaplastin test, 73%; and international normalized ratio (INR) of 1.36. Viral serology tests for hepatitis B and C were negative (Table [1](#ccr3546-tbl-0001){ref-type="table-wrap"}). On the 15th day, AST and ALT decreased rapidly. On the 15th day, risperidone therapy, at a dose of 4 mg/day, was started to treat his hallucinations and his chaotic and aggressive behavior. On the 19th day, his mental state was stabilized. His behavior improved. Therefore, intravenous infusion was discontinued. Meals were started. On the 22nd day, CK was normal, but ALP, ALT, AST, and GGT were elevated as shown in the Fig. [1](#ccr3546-fig-0001){ref-type="fig"}. Subsequently, we changed to slow‐release paliperidone 6 mg/day to treat his hallucinations and because of difficulty swallowing risperidone. From the 28th day, because his liver damage was suspected to have occurred as an adverse effect of risperidone therapy, blonanserin 8 mg/day was used instead. His liver function data subsequently returned to a normal range by the 43rd day. He was discharged in a stable condition with normal serum aminotransferases on the 67th day. His psychiatric condition and his health condition have remained stable.

###### 

Selected laboratory parameters

                                         Normal range            1st day                                    8th day   22nd day   43rd day   62nd day
  -------------------------------------- ----------------------- ------------------------------------------ --------- ---------- ---------- ----------
  Creatine kinase (CK)                   43--272 IU/L            6622                                       715       87         46         38
  Aspartate aminotransferase (AST)       8--40 IU/L              208                                        388       106        13         18
  Alanine aminotransferase (ALT)         5--35 IU/L              68                                         582       189        29         26
  Lactate dehydrogenase (LDH)            102--204 IU/L           562                                        513       295        147        141
  Alkaline phosphatase (ALP)             100--324 IU/L           209                                        212       433        286        274
  *γ*‐glutamyl transferase (GGT)         16--86 IU/L             27                                         43        150        63         64
  Cholinesterase (ChE)                   237--495 IU/L           --[a](#ccr3546-note-0002){ref-type="fn"}   221       --         --         --
  International normalized ratio (INR)   1.0--1.4                --                                         1.36      --         --         --
  Ammonia (NH~3~)                        12--66 *μ*g/dL          --                                         54        --         --         --
  Hepaplastin test (HPT)                 70--130%                --                                         73        --         --         --
  Myoglobin                              0--60 ng/mL             1644                                       168       --         --         --
  Total bilirubin                        0.2--1.2 mg/dL          --                                         1.02      --         --         --
  Direct bilirubin                       0--0.4 mg/dL            --                                         0.51      --         --         --
  Urea nitrogen                          8--20 mg/dL             18.5                                       12.9      7.3        10.2       11.7
  Creatinine                             0.6--1.1 mg/dL          1.09                                       0.85      0.67       0.73       0.85
  Sodium                                 135--148 mmol/L         144                                        135       141        140        139
  Potassium                              3.5--5 mmol/L           3.6                                        4.4       3.9        4.1        4.2
  Hepatitis B antigen                    Negative                Negative                                   --        --         --         --
  Hepatitis C antibody                   Negative                Negative                                   --        --         --         --
  C‐reactive protein                     0--0.3 mg/dL            0.58                                       0.96      0.59       --         --
  Red blood cell count                   400--540 × 10^4^/*μ*L   454                                        452       419        382        429
  Hemoglobin                             13--17 g/dL             13.8                                       13.9      12.8       11.8       13.2
  Hematocrit                             35--45%                 40.6                                       39.6      37.0       34.5       38.5
  White blood cell count                 3500--9100/*μ*L         8870                                       5590      7970       4030       4550

Not determined.
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![Time course changes of serum enzymes in the patient: green line, creatine kinase (CK); blue line, aspartate transaminase (AST); red line, alanine aminotransferase (ALT); yellow line, *γ*‐glutamyl transferase (GGT); and black line, alkaline phosphatase (ALP).](CCR3-4-469-g001){#ccr3546-fig-0001}

Discussion {#ccr3546-sec-0003}
==========

Results underscore two important clinical issues. The schizophrenic patient showed sudden onset of rhabdomyolysis. The intermixed pattern of intrahepatic and extrahepatic causes of ALT elevation is associated with respective clinical‐therapeutic events.

First, the patient suddenly developed rhabdomyolysis. Psychiatric patients with rhabdomyolysis often are asymptomatic [1](#ccr3546-bib-0001){ref-type="ref"}. The patient presented with rhabdomyolysis that was biochemically proven by an elevated CK (6622 IU/L) and AST (208 IU/L)/ALT (68 IU/L) ratio \>3, which, taken together with a normal ALP and GGT indicate an extrahepatic source of transaminitis. The most common causes of rhabdomyolysis are illicit drugs, medical drugs, muscular diseases, trauma, neuroleptic malignant syndrome, seizure, and immobility [4](#ccr3546-bib-0004){ref-type="ref"}. His past medical, medication, and family histories, respectively, rule out potential drug abuse, behavioral peculiarities such as psychogenic polydipsia and polyphagia, and genetic myopathy. Systemic bacterial infection is unlikely in the absence of inflammation of the blood chemistry tests. Unfortunately, we failed to ascertain what occurred with this patient immediately before admission. Because excessive physical activity is a major cause of rhabdomyolysis in psychiatric patients [1](#ccr3546-bib-0001){ref-type="ref"}, somewhat elevated CK concentration might result from his excessive physical activity and concurrent interruption of routine medication.

Second, the intermixed pattern of intrahepatic and extrahepatic causes of ALT elevation is associated with respective clinical‐therapeutic events. Given shorter half‐lives of CK and AST and the resuscitative measures undertaken for treating rhabdomyolysis [2](#ccr3546-bib-0002){ref-type="ref"}, [4](#ccr3546-bib-0004){ref-type="ref"}, [5](#ccr3546-bib-0005){ref-type="ref"}, [6](#ccr3546-bib-0006){ref-type="ref"}, [7](#ccr3546-bib-0007){ref-type="ref"}, serum concentrations of CK and AST improved more rapidly than ALT during the first few days, as shown in the Table [1](#ccr3546-tbl-0001){ref-type="table-wrap"} and Fig. [1](#ccr3546-fig-0001){ref-type="fig"}. Antipsychotic therapy started immediately after admission can be expected to cause liver dysfunction, which might explain the hepatotoxic pattern of overlapped elevation of ALT more than AST on days 4--8 of hospitalization that might be completely unrelated to rhabdomyolysis. This hypothesis is supported by a concomitant elevation of ALP and GGT (liver function biomarkers) and a continuous decrease in CK (rhabdomyolysis marker), as shown in the Fig. [1](#ccr3546-fig-0001){ref-type="fig"} and Table [1](#ccr3546-tbl-0001){ref-type="table-wrap"}. Consequently, this allegedly unusual and mysterious elevation of transaminases that is believed to result from psychotic rhabdomyolysis might reflect intermixed patterns of intrahepatic and extrahepatic causes of ALT elevation associated with respective clinical‐therapeutic events.

Two isoforms of ALT are ALT1 and ALT2. Actually, ALT1 and ALT2 appear to have not only different tissue sources but also cellular localization, suggesting dissimilar biological roles in the pathogenesis of acute or chronic liver disease [2](#ccr3546-bib-0002){ref-type="ref"}. ALT1 is encoded by a gene of *GPT1* located in chromosome 8 (8p24.3), but ALT2 is encoded by a different gene of *GPT2* located in chromosome 16 (16q12.1) [2](#ccr3546-bib-0002){ref-type="ref"}. ALT1, which is expressed primarily in liver [8](#ccr3546-bib-0008){ref-type="ref"}, and ALT2, which is expressed primarily in muscular tissue [9](#ccr3546-bib-0009){ref-type="ref"}, cannot be discriminated using current biochemical tests measuring serum ALT [2](#ccr3546-bib-0002){ref-type="ref"}. Recently, most activity in circulation is found to be attributed to ALT1 [10](#ccr3546-bib-0010){ref-type="ref"}. Furthermore, elevation of ALT concentrations does not necessarily indicate hepatocellular damage [11](#ccr3546-bib-0011){ref-type="ref"}. If two isoforms of ALT were applicable in clinical practice, then it might stimulate further insight into how these conflicting observations of seemingly unrelated clinical and biochemical events are explainable and reconciled.

In conclusion, facts associated with this case support the emerging evidence that aminotransferases are surrogate biomarkers of "liver metabolic function" beyond the classical concept of liver cellular damage because their enzymatic activity might actually reflect key aspects of the physiology and pathophysiology of the liver function [2](#ccr3546-bib-0002){ref-type="ref"}.
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